| KUCING # | Jeneng produk | Katrangan |
| CPDA0048 | Omarigliptin | Omarigliptin, uga dikenal minangka MK-3102, minangka inhibitor DPP-4 sing kuat lan dawa tumindak kanggo perawatan diabetes jinis 2 sepisan seminggu. |
| CPDA1089 | Retagliptin | Retagliptin, uga dikenal minangka SP-2086, minangka inhibitor DPP-4 sing bisa digunakake kanggo perawatan diabetes tipe 2. |
| CPDA0088 | Trelagliptin | Trelagliptin, uga dikenal minangka SYR-472, minangka inhibitor dipeptidyl peptidase-4 (DPP-4) tumindak dawa sing dikembangake dening Takeda kanggo perawatan diabetes tipe 2 (T2D). |
| CPDA2039 | Linagliptin | Linagliptin, uga dikenal minangka BI-1356, minangka inhibitor DPP-4 sing dikembangake dening Boehringer Ingelheim kanggo perawatan diabetes tipe II. |
| CPDA0100 | Sitagliptin | Sitagliptin (INN; sadurunge diidentifikasi minangka MK-0431 lan didol kanthi jeneng dagang Januvia) minangka antihiperglikemik oral (obat anti-diabetes) saka kelas inhibitor dipeptidyl peptidase-4 (DPP-4). |
